Colony Group LLC Astrazeneca PLC Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Colony Group LLC holds 27,927 shares of AZN stock, worth $1.86 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

27,927

Previous 28,146 0.78%

Holding current value

$1.86 Million

Previous $2.01 Million 6.11%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $14,202 - $15,702	-219 Reduced 0.78%	27,927 $1.89 Million
Q2 2023 Aug 15, 2023	BUY	$69.91 - $75.81 $16,498 - $17,891	236 Added 0.85%	28,146 $2.01 Million
Q1 2023 May 16, 2023	SELL	$63.15 - $71.6 $204,163 - $231,482	-3,233 Reduced 10.38%	27,910 $1.94 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $459,863 - $597,542	8,483 Added 37.44%	31,143 $2.11 Million
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $31,705 - $81,178	598 Added 2.71%	22,660 $1.24 Million
Q2 2022 Aug 16, 2022	BUY	$59.26 - $71.14 $240,358 - $288,543	4,056 Added 22.53%	22,062 $1.46 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $19,669 - $23,693	353 Added 2.0%	18,006 $1.2 Million
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $109,120 - $128,936	2,020 Added 12.92%	17,653 $1.03 Million
Q3 2021 Nov 17, 2021	BUY	$55.56 - $60.79 $37,225 - $40,729	670 Added 4.48%	15,633 $939,000
Q2 2021 Aug 18, 2021	SELL	$48.42 - $60.18 $85,800 - $106,638	-1,772 Reduced 10.59%	14,963 $896,000
Q1 2021 May 21, 2021	SELL	$47.16 - $54.44 $54,281 - $62,660	-1,151 Reduced 6.44%	16,735 $832,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $291,265 - $348,294	6,003 Added 50.52%	17,886 $894,000
Q3 2020 Nov 17, 2020	BUY	$53.07 - $61.1 $68,460 - $78,819	1,290 Added 12.18%	11,883 $651,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $35,126 - $45,077	815 Added 8.34%	10,593 $560,000
Q1 2020 May 18, 2020	BUY	$37.79 - $51.33 $14,435 - $19,608	382 Added 4.07%	9,778 $437,000
Q4 2019 Feb 18, 2020	BUY	$42.46 - $50.46 $16,474 - $19,578	388 Added 4.31%	9,396 $468,000
Q3 2019 Nov 26, 2019	SELL	$40.12 - $45.47 $23,710 - $26,872	-591 Reduced 6.16%	9,008 $401,000
Q2 2019 Aug 19, 2019	SELL	$37.28 - $41.68 $72,024 - $80,525	-1,932 Reduced 16.75%	9,599 $396,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $409,235 - $496,063	11,531 New	11,531 $466,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account